Sanford Wohlstadter
Obstetrics & Gynecology · Holmdel, NJNPI 1649268616
Payments from drug & device makers
Across 36 payments — averaging $38.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Celularity Inc.$600
- Hologic Sales And Service, LLC$181
- Astellas Pharma US Inc$134
- Medtronic$117
- Dysis Medical, Inc.$52
- Sumitomo Pharma America, Inc.$50
- plus $261 from 12 others
What the payments were for
- Consulting fees$191%
- Speaking & faculty fees$60043%
- Food & beverage$66347%
- Education$1148%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Celularity Inc. | 2 | $600 |
| Hologic Sales And Service, LLC | 5 | $181 |
| Astellas Pharma US Inc | 3 | $134 |
| Medtronic | 2 | $117 |
| Dysis Medical, Inc. | 3 | $52 |
| Sumitomo Pharma America, Inc. | 3 | $50 |
| Bayer | 2 | $44 |
| Aspira Women's Health Inc | 2 | $32 |
| Mayne Pharma Commercial LLC | 3 | $32 |
| Vertical Pharmaceuticals, LLC | 2 | $30 |
| Coopersurgical, Inc. | 2 | $27 |
| Evofem Biosciences, Inc. | 1 | $19 |
| Medicem Inc. | 1 | $15 |
| AbbVie | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Exeltis, USA Inc. | 1 | $14 |
| Duchesnay USA Incorporated | 1 | $12 |
| Channel Medsystems, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$105
How this compares
$1,396 in reported general payments places this provider in the 65th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremproEstrogen,con/M-Progest Acet | 19 | $6,410 |
| Estradiol | 84 | $3,689 |
| Ibandronate Sodium | 76 | $2,269 |
| Raloxifene Hcl | 24 | $503 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 41 | $497 |
| Terconazole | 11 | $349 |
| Oxybutynin Chloride ErOxybutynin Chloride | 20 | $320 |
| ValacyclovirValacyclovir Hcl | 15 | $197 |
| Medroxyprogesterone Acetate | 15 | $163 |
| Alendronate Sodium | 12 | $157 |
| Fluconazole | 28 | $62 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Holmdel
- Robert PenneyHolmdel$19K
- Jennifer AshtonEnglewood$1.5M
- Gregory HirschMorristown$1.3M
- Steven SussmanLawrenceville$623K
- Geoffrey BowersVoorhees$228K
- Neha DeshpandePlainsboro$206K
- Justin ChuraSwedesboro$193K
- Paula JasionowskiVoorhees$193K
- Peter ChenSewell$191K
- Andrea VentolaFlorham Park$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.